Latest Articles
Optimizing Biomarker-Driven Treatment and Immune Checkpoint Inhibitor Counseling in Endometrial Cancer - Pharmacy Times
Optimizing Biomarker-Driven Treatment and Immune Checkpoint Inhibitor Counseling in Endometrial Cancer Pharmacy Times
Published: May 28, 2026, 8:50 p.m.
Biomarker Testing and Immune Checkpoint Inhibitor Counseling Shape Endometrial Cancer Care - Pharmacy Times
Biomarker Testing and Immune Checkpoint Inhibitor Counseling Shape Endometrial Cancer Care Pharmacy Times
Published: May 27, 2026, 4:12 p.m.
Immune Checkpoint Inhibitors Transform Frontline Endometrial Cancer Care - Pharmacy Times
Immune Checkpoint Inhibitors Transform Frontline Endometrial Cancer Care Pharmacy Times
Published: May 26, 2026, 3:57 p.m.
Soluble immune checkpoints in endometrial cancer – a discovery study - Frontiers
Soluble immune checkpoints in endometrial cancer – a discovery study Frontiers
Published: Nov. 3, 2025, 4:27 p.m.
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma - Nature.com
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma Nature.com
Published: Jan. 9, 2025, 7:28 a.m.
Link copied to clipboard!